Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6435661 | 0.78 | TSHR (0.48) | TSHR | |
| SCHEMBL195771 | 0.74 | TSHR (0.52) | TSHR | |
| SCHEMBL11196432 | 0.71 | TSHR (0.44) | TSHR | |
| SCHEMBL278045 | 0.69 | — | — | |
| SCHEMBL93377 | 0.67 | — | — | |
| SCHEMBL1414796 | 0.67 | — | — | |
| SCHEMBL7828526 | 0.67 | ALDH1A1 (0.32) | — | |
| SCHEMBL536303 | 0.67 | — | — | |
| Water SCHEMBL11221025 | 0.65 | ALDH1A1 (0.31) | — | |
| SCHEMBL11559594 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 247 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112513053-B | Aluminum compound and method for forming aluminum-containing film using the same | UP化学株式会社 | 2024-02-23 | — | — | CN | claimed |
| CN-116964808-A | Flame-resistant quasi-solid and solid electrolyte for lithium ion and lithium metal batteries and method for producing same | 环球石墨烯集团公司 | 2023-10-27 | — | — | CN | claimed |
| US-20220411394-A1 | Lipid Nanoparticles for Delivery of Nucleic Acids and Methods of Use Thereof | AKAGERA MEDICINES, INC. (US) | 2022-12-29 | — | — | US | claimed |
| US-20220231333-A1 | QUASI-SOLID AND SOLID-STATE ELECTROLYTE FOR LITHIUM-ION AND LITHIUM METAL BATTERIES AND MANUFACTURING METHOD | HONEYCOMB BATTERY COMPANY | 2022-07-21 | — | — | US | claimed |
| WO-2022150849-A1 | FLAME-RESISTANT QUASI-SOLID AND SOLID-STATE ELECTROLYTE FOR LITHIUM-ION AND LITHIUM METAL BATTERIES AND PRODUCTION METHOD | GLOBAL GRAPHENE GROUP, INC. (US) | 2022-07-14 | — | — | WO | claimed |
| EP-2804921-B1 | PROCESS FOR THE ENHANCED RECOVERY OF OIL BY INJECTION OF A POLYMER SOLUTION | SPCM SA (FR) | 2020-08-26 | — | — | EP | claimed |
| EP-1719784-B1 | Alcohol compatible copolymer | AKZO NOBEL NV (NL) | 2015-04-08 | — | — | EP | claimed |
| US-8540974-B2 | Aqueous dispersions of water-soluble and/or water-swellable anionic polymers, method for their production and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2013-09-24 | — | — | US | claimed |
| US-8329622-B2 | Alcohol compatible copolymer | AKZO NOBEL N.V. (NL) | 2012-12-11 | — | — | US | claimed |
| US-20120220567-A1 | BENZO-FUSED OXAZEPINE COMPOUNDS AS STEAROYL-COENZYME A DELTA-9 DESATURASE INHIBITORS | SCHERING CORPORATION | 2012-08-30 | — | — | US | claimed |
| EP-1651693-B1 | AQUEOUS DISPERSIONS OF HYDROSOLUBLE POLYMERISATES OF ETHYLENICALLY UNSATURATED ANIONIC MONOMERS, METHOD FOR THE PRODUCTION AND USE THEREOF | BASF AG (DE) | 2006-12-20 | — | — | EP | claimed |
| EP-1636238-A1 | HETERORYL-FUSED PYRIMIDINYL COMPOUNDS AS ANTICANCER AGENTS | Chiron Corporation (US) | 2006-03-22 | — | — | EP | claimed |
| US-20050065169-A1 | Heteroaryl-fused pyrimidinyl compounds as anticancer agents | CHIRON CORPORATION | 2005-03-24 | — | — | US | claimed |
| WO-2004111058-A1 | HETERORYL-FUSED PYRIMIDINYL COMPOUNDS AS ANTICANCER AGENTS | CHIRON CORPORATION (US) | 2004-12-23 | — | — | WO | claimed |
| US-5965300-A | MIXING MONOMERS SUCH AS (METH)ACRYLAMIDES A CROSSLINKING AGENT, POLYMERIZATION INITIATOR AND ELECTROLYTE SOLUTION CONTAINING LITHIUM SALT AND SOLVENT, ADDING THE MIXTURE TO POLYVINYLIDENE AND /OR N,N-DIALKYLACRYLAMIDE; POLYMERIZING | SAMSUNG ELECTROONICS CO., LTD. (KR) | 1999-10-12 | — | — | US | claimed |
| US-5952126-A | COPOLYMER OF A (METH)ACRYLAMIDE MONOMER AND A CROSSLINKING AGENT COMPRISING A DI(METH)ACRYLATE ENDCAPPED ETHYLENE GLYCOL HAVING 3-30 REPEATING ETHYLENE OXIDE UNITS; NONLEAKING, EXCELLENT CONDUCTIVITY, EASILY PROCESSED | SAMSUNG ELECTRONICS CO., LTD. (KR) | 1999-09-14 | — | — | US | claimed |
| EP-0812618-A2 | Resin fibers for treatment of oil bearing waste water and method of treating oil bearing waste water | NEC CORPORATION (JP) | 1997-12-17 | — | — | EP | claimed |
| EP-0533776-A1 | POLYMERIC FILMS FOR FORMING CAPSULE SHELLS | Ciba Specialty Chemicals Water Treatments Limited (GB) | 1993-03-31 | — | — | EP | claimed |
| WO-1991019487-A1 | POLYMERIC FILMS FOR FORMING CAPSULE SHELLS | ALLIED COLLOIDS LIMITED (GB) | 1991-12-26 | — | — | WO | claimed |
| US-4081542-A | ANOREXIC AGENTS | MERCK & CO., INC. (US) | 1978-03-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120220567-A1 | BENZO-FUSED OXAZEPINE COMPOUNDS AS STEAROYL-COENZYME A DELTA-9 DESATURASE INHIBITORS | SCD, SCD5, CPT1A | TSHR 3435/4885 |
| US-20220411394-A1 | Lipid Nanoparticles for Delivery of Nucleic Acids and Methods of Use Thereof | ASGR1, LDLR, CD2BP2 | TSHR 1450/4885 |
| US-20050065169-A1 | Heteroaryl-fused pyrimidinyl compounds as anticancer agents | TYMP, DHFR, PAICS | TSHR 3471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.